Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Horizon Europe (2021 - 2027)

AI-Powered Signal Detection in Pharmacovigilance

Last update: 2 days ago Last update: Jun 17, 2025

Details

Location:EU 27
EU 27
Funding agency:
Horizon Europe (2021 - 2027)
Contracting authority type:Development Institution
Status:Open
Budget:N/A
Award ceiling: EUR 8,906,000
Award floor:N/A
Sector:Health, Science & Innovation, Research
Languages:English
Eligible applicants:Unrestricted / Unspecified
Eligible citizenships:EU 27, Afghanistan, Albania, Alg ...
See more EU 27, Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Aruba, Azerbaijan, Bangladesh, Belarus, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Cuba, Curaçao, Dem. Rep. Congo, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Eswatini (Swaziland), Ethiopia, Fiji, French Polynesia, French Southern Territory, Gabon, Gambia, Georgia, Ghana, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Iceland, Indonesia, Iran, Iraq, Israel, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Lebanon, Lesotho, Liberia, Libya, Madagascar, Malawi, Malaysia, Maldives, Mali, Marshall Islands, Mauritania, Mauritius, Micronesia, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nepal, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, North Macedonia, Norway, Pakistan, Palau, Palestine / West Bank & Gaza, Papua New Guinea, Paraguay, Peru, Philippines, Rwanda, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Sierra Leone, Sint Maarten, Solomon Islands, Somalia, South Africa, South Sudan, Sri Lanka, St. Pierre and Miquelon, Sudan, Suriname, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, UK, Ukraine, Uzbekistan, Vanuatu, Venezuela, Vietnam, Wallis and Futuna, Yemen, Zambia, Zimbabwe
Date posted: Jun 17, 2025

Attachments • 21

Quick summary

AI generated
Objectives: The 'AI-Powered Signal Detection in Pharmacovigilance' initiative aims to enhance drug safety and patient protection. The project focuses on developing AI algorithms for faster, more accurate signal detection of adverse drug reactions. It intends to create a comprehensive list of data sources to improve signal detection and risk prediction, fostering proactive measures to mitigate risks before they escalate. Expected outcomes include improved decision-making through AI insights, streamlined pharmacovigilance tasks, and support for shaping future regulations through the use of AI.
Eligibility criteria: Entities eligible to apply are legal entities that are established within EU member states or associated countries under Horizon Europe's work programme. Non-EU countries are generally not eligible unless th...

Description

AI-Powered Signal Detection in Pharmacovigilance TOPIC ID: HORIZON-JU-IHI-2025-11-03-two-stage Type of grant: Call for proposals General information Programme: Call: Innovative Health Initiative JU Call 11 (HORIZON-JU-IHI-2025-11-two-stage) Type of action
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 112+ donors and banks are available here
Learn more about our membership benefits
Print
Similar grants
By Locations
Draper Richards Kaplan Foundat
Draper Richards Kaplan Foundation Grants for Entrepreneurs and NGOs
Draper Richards Kaplan Foundation Grants for Entrepreneurs and NGOs
Funding agency:
NPO
Status:
open
Location:
Africa, EU 27, Europe Non EU 27, Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, French Guiana, Guatemala, Guyana, Honduras, India, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay, USA, Venezuela
CFAs: Development of Minority
CFAs: Development of Minority Co-Production Scheme
CFAs: Development of Minority Co-Production Scheme
Funding agency:
NPO
Status:
open
Location:
EU 27, Iceland, Liechtenstein, Norway, Switzerland
View 1147 more
By Sectors
Call for Proposals: Challenge
Call for Proposals: Challenge Program - Biological Systems under Non-equilibrium Conditions
Call for Proposals: Challenge Program - Biological Systems under Non-equilibrium Conditions
Funding agency:
NPO
Status:
open
Location:
Austria, Belgium, Bulgaria, Caribbean Netherlands, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK
PEPR MIE 2025 -Volet 1, 2 and
PEPR MIE 2025 -Volet 1, 2 and 3
PEPR MIE 2025 -Volet 1, 2 and 3
Funding agency:
Government
Status:
open
Location:
France
View 26 more